Matches in SemOpenAlex for { <https://semopenalex.org/work/W4306403915> ?p ?o ?g. }
- W4306403915 abstract "In view of limited evidence that specifically addresses vaccine effectiveness (VE) in the older population, this study aims to evaluate the real-world effectiveness of BNT162b2 and CoronaVac in older adults during the Omicron BA.2 outbreak.This case-control study analyzed data available between January and March 2022 from the electronic health databases in Hong Kong and enrolled individuals aged 60 or above. Each case was matched with up to 10 controls by age, sex, index date and Charlson Comorbidity Index for the four outcomes (COVID-19 infection, COVID-19-related hospitalization, severe complications, and all-cause mortality) independently. Conditional logistic regression was conducted to evaluate VE of BNT162b2 and CoronaVac against COVID-19-related outcomes within 28 days after COVID-19 infection among participants stratified by age groups (60-79, ≥80 years old).A dose-response relationship between the number of vaccine doses received and protection against severe or fatal disease was observed. Highest VE (95% CI) against COVID-19 infection was observed in individuals aged ≥80 who received three doses of BNT162b2 [75.5% (73.1-77.7%)] or three doses of CoronaVac [53.9% (51.0-56.5%)] compared to those in the younger age group who received three doses of BNT162b2 [51.1% (49.9-52.4%)] or three doses of CoronaVac [2.0% (-0.1-4.1%)]. VE (95% CI) was higher for other outcomes, reaching 91.9% (89.4-93.8%) and 86.7% (84.3-88.8%) against COVID-19-related hospitalization; 85.8% (61.2-94.8%) and 89.8% (72.4-96.3%) against COVID-19-related severe complications; and 96.4% (92.9-98.2%) and 95.0% (92.1-96.8%) against COVID-19-related mortality after three doses of BNT162b2 and CoronaVac in older vaccine recipients, respectively. A similar dose-response relationship was established in younger vaccine recipients and after stratification by sex and Charlson Comorbidity Index.Both BNT162b2 and CoronaVac vaccination were effective in protecting older adults against COVID-19 infection and COVID-19-related severe outcomes amidst the Omicron BA.2 pandemic, and VE increased further with the third dose." @default.
- W4306403915 created "2022-10-17" @default.
- W4306403915 creator A5004488408 @default.
- W4306403915 creator A5027719632 @default.
- W4306403915 creator A5033684035 @default.
- W4306403915 creator A5035152212 @default.
- W4306403915 creator A5041610413 @default.
- W4306403915 creator A5043051253 @default.
- W4306403915 creator A5051098098 @default.
- W4306403915 creator A5063190766 @default.
- W4306403915 creator A5065186433 @default.
- W4306403915 creator A5066384550 @default.
- W4306403915 creator A5082409466 @default.
- W4306403915 creator A5090788920 @default.
- W4306403915 date "2022-10-17" @default.
- W4306403915 modified "2023-10-17" @default.
- W4306403915 title "Effectiveness of BNT162b2 and CoronaVac vaccinations against SARS-CoV-2 omicron infection in people aged 60 years or above: a case–control study" @default.
- W4306403915 cites W3024344902 @default.
- W4306403915 cites W3044678576 @default.
- W4306403915 cites W3092837137 @default.
- W4306403915 cites W3093367571 @default.
- W4306403915 cites W3109516676 @default.
- W4306403915 cites W3111255098 @default.
- W4306403915 cites W3127600917 @default.
- W4306403915 cites W3141986261 @default.
- W4306403915 cites W3158247426 @default.
- W4306403915 cites W3158276912 @default.
- W4306403915 cites W3164094536 @default.
- W4306403915 cites W3164720238 @default.
- W4306403915 cites W3176552995 @default.
- W4306403915 cites W3178010802 @default.
- W4306403915 cites W3179399516 @default.
- W4306403915 cites W3193761537 @default.
- W4306403915 cites W3195921287 @default.
- W4306403915 cites W3205044984 @default.
- W4306403915 cites W3209085375 @default.
- W4306403915 cites W4200398760 @default.
- W4306403915 cites W4205240144 @default.
- W4306403915 cites W4205962841 @default.
- W4306403915 cites W4206137945 @default.
- W4306403915 cites W4206390478 @default.
- W4306403915 cites W4206757477 @default.
- W4306403915 cites W4206906464 @default.
- W4306403915 cites W4207009506 @default.
- W4306403915 cites W4210640048 @default.
- W4306403915 cites W4210747042 @default.
- W4306403915 cites W4210844692 @default.
- W4306403915 cites W4210860013 @default.
- W4306403915 cites W4210887330 @default.
- W4306403915 cites W4212842578 @default.
- W4306403915 cites W4214649932 @default.
- W4306403915 cites W4214921875 @default.
- W4306403915 cites W4220709838 @default.
- W4306403915 cites W4220750168 @default.
- W4306403915 cites W4220946269 @default.
- W4306403915 cites W4220999911 @default.
- W4306403915 cites W4223898721 @default.
- W4306403915 cites W4224230335 @default.
- W4306403915 cites W4224244390 @default.
- W4306403915 cites W4225740414 @default.
- W4306403915 cites W4225855631 @default.
- W4306403915 cites W4226054307 @default.
- W4306403915 cites W4226244948 @default.
- W4306403915 cites W4226246286 @default.
- W4306403915 cites W4226318522 @default.
- W4306403915 cites W4226391586 @default.
- W4306403915 cites W4281399377 @default.
- W4306403915 cites W4281489105 @default.
- W4306403915 cites W4281691419 @default.
- W4306403915 cites W4281827985 @default.
- W4306403915 cites W4282838915 @default.
- W4306403915 cites W4282934112 @default.
- W4306403915 cites W4283807799 @default.
- W4306403915 cites W4285606826 @default.
- W4306403915 cites W4288095952 @default.
- W4306403915 cites W4289643890 @default.
- W4306403915 doi "https://doi.org/10.1093/jtm/taac119" @default.
- W4306403915 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36250571" @default.
- W4306403915 hasPublicationYear "2022" @default.
- W4306403915 type Work @default.
- W4306403915 citedByCount "4" @default.
- W4306403915 countsByYear W43064039152023 @default.
- W4306403915 crossrefType "journal-article" @default.
- W4306403915 hasAuthorship W4306403915A5004488408 @default.
- W4306403915 hasAuthorship W4306403915A5027719632 @default.
- W4306403915 hasAuthorship W4306403915A5033684035 @default.
- W4306403915 hasAuthorship W4306403915A5035152212 @default.
- W4306403915 hasAuthorship W4306403915A5041610413 @default.
- W4306403915 hasAuthorship W4306403915A5043051253 @default.
- W4306403915 hasAuthorship W4306403915A5051098098 @default.
- W4306403915 hasAuthorship W4306403915A5063190766 @default.
- W4306403915 hasAuthorship W4306403915A5065186433 @default.
- W4306403915 hasAuthorship W4306403915A5066384550 @default.
- W4306403915 hasAuthorship W4306403915A5082409466 @default.
- W4306403915 hasAuthorship W4306403915A5090788920 @default.
- W4306403915 hasBestOaLocation W43064039151 @default.
- W4306403915 hasConcept C116675565 @default.
- W4306403915 hasConcept C126322002 @default.
- W4306403915 hasConcept C151956035 @default.
- W4306403915 hasConcept C159047783 @default.